<- Go Home

Shanghai United Imaging Healthcare Co., Ltd.

Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. Its molecular imaging products include uEXPLORER, uPMR 790, uMI 780, uMI Vista, and uMI 550; and magnetic resonance imaging solutions comprise uMR 5T, uMR Omega, uMR 790, uMR 780, and uMR 770, uMR 680, uMR 670, uMR588, uMR 580, and uMR570. The company also offers computed tomography equipment, such as uCT 960+, uCT 780, uCT 760, uCT 530, uCT 528, and uCT 520; digital radiography equipment, including uDR 780i Pro, uDR 596i, uDR 566i, uDR 592h, uDR 266i, uDR 380i, uMammo 890i, uMammo 590i, and uMC 560i; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; ultra-low dose, high resolution three-dimensional breast imaging technology application solution; uStereo stereotaxic biopsy system, a biopsy positioning system that provides an intelligent and precise positioning workflow for breast biopsy; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software, used to analyze functional magnetic resonance imaging and diffusion tensor imaging data; and U-VIEWER, a software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.

Market Cap

CNY 108.2B

Volume

3.1M

Cash and Equivalents

CNY 6.3B

EBITDA

CNY 1.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CNY 5.3B

Profit Margin

48.55%

52 Week High

CNY 159.32

52 Week Low

CNY 92.00

Dividend

0.18%

Price / Book Value

5.62

Price / Earnings

68.32

Price / Tangible Book Value

5.93

Enterprise Value

CNY 99.2B

Enterprise Value / EBITDA

61.86

Operating Income

CNY 1.2B

Return on Equity

8.44%

Return on Assets

3.05

Cash and Short Term Investments

CNY 9.1B

Debt

CNY 134.3M

Equity

CNY 19.2B

Revenue

CNY 10.9B

Unlevered FCF

-CNY 2.9B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches